Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS).
about
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional studyA further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma: A nationwide study of a cohort from Taiwan.Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
P2860
Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Long-acting injectable risperi ...... -interventional study (InORS).
@en
Long-acting injectable risperi ...... -interventional study (InORS).
@nl
type
label
Long-acting injectable risperi ...... -interventional study (InORS).
@en
Long-acting injectable risperi ...... -interventional study (InORS).
@nl
prefLabel
Long-acting injectable risperi ...... -interventional study (InORS).
@en
Long-acting injectable risperi ...... -interventional study (InORS).
@nl
P2093
P2860
P1476
Long-acting injectable risperi ...... -interventional study (InORS).
@en
P2093
Anders Svensson
Andreas Schreiner
Larisa Serazetdinova
Mathias Zink
Patricia Princet
Pierre Cherubin
Robert Wapenaar
P2860
P304
P356
10.3109/15622975.2014.902990
P577
2014-04-29T00:00:00Z